No mucositis symptoms yet present
Prevention of OM can be achieved in 37.24% of cases by using GelX® during cancer treatment.5
Soreness and/or erythema (the medical term for redness of the skin caused by injury or inflammation)
GelX® blocks exposed nerve endings for effective relief, and reduces inflammation.1,7
Erythema and ulcers present but you can swallow solid food.
GelX® provides a bio-adhesive barrier for durable protection and coats oral lesions to soothe and relieve pain.1
Ulcers with extensive erythema Solid food cannot be swallowed
Swallowing and eating difficulties were reduced in patients using GelX®, compared with oral mucositis symptoms from previous cycles treated with the same therapeutic measures without GelX®.7
Severe oral mucositis Unable to eat or drink
The duration of oral mucositis was shorter after including GelX® during cancer treatment, and the severity of the condition was also improved.7